LXRX•benzinga•
Piper Sandler Maintains Overweight on Lexicon Pharmaceuticals, Lowers Price Target to $6
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 7, 2025 by benzinga